Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

PRKAR1A Produits

(Protein Kinase, CAMP-Dependent, Regulatory, Type I, alpha (Tissue Specific Extinguisher 1) (PRKAR1A))

Catégories

cAMP is a signaling molecule important for a variety of cellular functions. cAMP exerts its effects by activating the cAMP-dependent protein kinase, which transduces the signal through phosphorylation of different target proteins. The inactive kinase holoenzyme is a tetramer composed of two regulatory and two catalytic subunits. cAMP causes the dissociation of the inactive holoenzyme into a dimer of regulatory subunits bound to four cAMP and two free monomeric catalytic subunits. Four different regulatory subunits and three catalytic subunits have been identified in humans. This gene encodes one of the regulatory subunits. This protein was found to be a tissue-specific extinguisher that down-regulates the expression of seven liver genes in hepatoma x fibroblast hybrids. Mutations in this gene cause Carney complex (CNC). This gene can fuse to the RET protooncogene by gene rearrangement and form the thyroid tumor-specific chimeric oncogene known as PTC2. A nonconventional nuclear localization sequence (NLS) has been found for this protein which suggests a role in DNA replication via the protein serving as a nuclear transport protein for the second subunit of the Replication Factor C (RFC40). Several alternatively spliced transcript variants encoding two different isoforms have been observed. [provided by RefSeq, Jan 2013].

antibodies-online.com est synonyme de produits de recherche de haute qualité. Cherchez, trouvez et commandez des outils avec des données de validation étendues, des images, des références. Notre service clientèle scientifique est toujours à votre disposition si vous avez des questions sur la sélection ou l'application de nos produits.

Catégories PRKAR1A en vedette

PRKAR1A Anticorps

High quality antibodies with extensive validation data.

PRKAR1A Protéines

Proteins for various applications incl. WB, ELISA, IF etc.

PRKAR1A recommandé Anticorps

Produit
Reactivity
Application
Validations
N° du produit
Quantité
Fiche technique
Reactivity Human
Application WB, IF
Validations
  • (5)
N° du produit ABIN3021148
Quantité 100 μL
Fiche technique Fiche technique
Reactivity Human, Mouse, Rat
Application WB, ELISA, IHC, IF, ICC
Validations
  • (3)
N° du produit ABIN6264423
Quantité 100 μL
Fiche technique Fiche technique
Reactivity Human, Rat
Application WB, IHC (p)
Validations
  • (4)
N° du produit ABIN5518788
Quantité 100 μg
Fiche technique Fiche technique

PRKAR1A recommandé Kits ELISA

Produit
Reactivity
Analytical Method
Validations
N° du produit
Quantité
Fiche technique
Reactivity Human, Mouse, Rat
Analytical Method Qualitative Cell ELISA
Validations
N° du produit ABIN5648035
Quantité 96 tests
Fiche technique Fiche technique
Reactivity Human
Analytical Method Quantitative Sandwich ELISA
Validations
N° du produit ABIN6730540
Quantité 96 tests
Fiche technique Fiche technique

PRKAR1A recommandé Protéines

Produit
Reactivity
Source
Validations
N° du produit
Quantité
Fiche technique
Reactivity Human
Source Wheat germ
Validations
  • (1)
N° du produit ABIN1316241
Quantité 10 μg
Fiche technique Fiche technique
Reactivity Human
Source Wheat germ
Validations
  • (1)
N° du produit ABIN1316243
Quantité 10 μg
Fiche technique Fiche technique
Reactivity Human
Source Human Cells
Validations
N° du produit ABIN7318228
Quantité 50 μg
Fiche technique Fiche technique

Dernières publications sur nos produits PRKAR1A

Graham, Lackner, Terracciano, González-Cantú, Maleszewski, Greipp, Simon, Torbenson: "Fibrolamellar carcinoma in the Carney complex: PRKAR1A loss instead of the classic DNAJB1-PRKACA fusion." dans: Hepatology (Baltimore, Md.), Vol. 68, Issue 4, pp. 1441-1447, (2019) (PubMed).

Graham, Terracciano, Meves, Vanderboom, Dasari, Yeh, Torbenson, Cruise: "Hepatic adenomas with synchronous or metachronous fibrolamellar carcinomas: both are characterized by LFABP loss." dans: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, Vol. 29, Issue 6, pp. 607-15, (2018) (PubMed).

Cao, Xia, Zhou, Yang, Hao, Peng, Liu, Zhu: "Methylcrotonoyl-CoA carboxylase 1 potentiates RLR-induced NF-κB signaling by targeting MAVS complex." dans: Scientific reports, Vol. 6, pp. 33557, (2016) (PubMed).

Sousa, Gomez, Diniz, Bernardes, Soares, Brito, Liu, Pontes, Stratakis, Gomes: "Defects of the Carney complex gene (PRKAR1A) in odontogenic tumors." dans: Endocrine-related cancer, Vol. 22, Issue 3, pp. 399-408, (2015) (PubMed).

Maleszewski, Larsen, Kip, Castonguay, Edwards, Carney, Kipp: "PRKAR1A in the development of cardiac myxoma: a study of 110 cases including isolated and syndromic tumors." dans: The American journal of surgical pathology, Vol. 38, Issue 8, pp. 1079-87, (2014) (PubMed).

Wells, OReilly, Szul, Sullivan, Handley, Garrett, McNicholas, Roda, Miller, Tal-Singer, Gaggar, Rennard, Jackson, Blalock: "An aberrant leukotriene A4 hydrolase-proline-glycine-proline pathway in the pathogenesis of chronic obstructive pulmonary disease." dans: American journal of respiratory and critical care medicine, Vol. 190, Issue 1, pp. 51-61, (2014) (PubMed).

Shajahan-Haq, Cook, Schwartz-Roberts, Eltayeb, Demas, Warri, Facey, Hilakivi-Clarke, Clarke: "MYC regulates the unfolded protein response and glucose and glutamine uptake in endocrine resistant breast cancer." dans: Molecular cancer, Vol. 13, pp. 239, (2014) (PubMed).

Zhao, Li, Wohlford-Lenane, Agnihothram, Fett, Zhao, Gale, Baric, Enjuanes, Gallagher, McCray, Perlman: "Rapid generation of a mouse model for Middle East respiratory syndrome." dans: Proceedings of the National Academy of Sciences of the United States of America, Vol. 111, Issue 13, pp. 4970-5, (2014) (PubMed).

Tian, Jiang, Tamosiuniene, Sung, Qian, Dhillon, Gera, Farkas, Rabinovitch, Zamanian, Inayathullah, Fridlib, Rajadas, Peters-Golden, Voelkel, Nicolls: "Blocking macrophage leukotriene b4 prevents endothelial injury and reverses pulmonary hypertension." dans: Science translational medicine, Vol. 5, Issue 200, pp. 200ra117, (2013) (PubMed).

Wang, Henry, Distefano, Wang, Räikkönen, Mönkkönen, Tanaka, Morita: "Butyrophilin 3A1 plays an essential role in prenyl pyrophosphate stimulation of human V?2V?2 T cells." dans: Journal of immunology (Baltimore, Md. : 1950), Vol. 191, Issue 3, pp. 1029-42, (2013) (PubMed).

Synonymes et noms alternatifs relatifs à PRKAR1A

protein kinase cAMP-dependent type I regulatory subunit alpha (PRKAR1A), protein kinase, cAMP dependent regulatory, type I, alpha (Prkar1a), protein kinase cAMP-dependent type 1 regulatory subunit alpha (Prkar1a), protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1) a (prkar1aa), cAMP-dependent protein kinase type I-alpha regulatory subunit pseudogene (LOC707275), protein kinase cAMP-dependent type I regulatory subunit alpha (Prkar1a), protein kinase cAMP-dependent type I regulatory subunit alpha S homeolog (prkar1a.S), 1300018C22Rik, ACRDYS1, ADOHR, CAR, CNC, CNC1, cnc1, im:7047729, PKR1, pkr1, PPNAD1, ppnad1, PRKAR1, prkar1, prkar1a, RIalpha, RIIA, Tse-1, TSE1, Tse1, tse1, zgc:92515

Protein level used designations for PRKAR1A

  • cAMP-dependent protein kinase regulatory subunit RIalpha
  • cAMP-dependent protein kinase type I-alpha regulatory chain
  • cAMP-dependent protein kinase type I-alpha regulatory subunit
  • protein kinase A type 1a regulatory subunit
  • tissue-specific extinguisher 1
  • protein kinase, cAMP dependent regulatory, type 1, alpha
  • protein kinase, cAMP dependent regulatory, type I, alpha
  • cAMP-dependent protein kinase type I regulatory subunit
  • protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1)
  • cAMP-dependent protein kinase, regulatory subunit alpha 1
  • cAMP-dependent protein kinase regulatory subunit alpha 1
  • cAMP-dependent protein kinase type I-alpha regulatory subunit-like
  • protein kinase, cAMP-dependent, regulatory subunit type I alpha S homeolog
Vous êtes ici:
Support technique